|
Variables
|
Crude effect measure (95% CI)
|
P value
|
Adjusted effect measure (95% CI)
|
P value
|
|---|
|
Crude OR (95% CI)
|
Adjusted OR (95% CI)
|
|---|
|
ICU admission (as outcome)
|
|
HScore
|
|
Moderate
|
2.95 (1.35–6.44)
|
0.007
|
4.58 (1.78–11.79)
|
0.002
|
|
High
|
3.4 (1.40–8.22)
|
0.007
|
4.93 (1.50–16.17)
|
0.008
|
|
Overweight
|
0.39 (0.20–o.75)
|
0.005
|
0.35 (0.14–0.82)
|
0.017
|
|
Diastolic Blood pressure
|
0.95 (0.93–0.98)
|
0.002
|
0.96 (0.92–0.99)
|
0.046
|
|
Loss of appetite
|
0.11 (0.01–0.9)
|
0.040
|
0.20 (0.001–0.25)
|
0.002
|
|
Fatigue
|
1.04 (0.50–2.19)
|
0.899
|
5.25 (1.67–16.48)
|
0.004
|
|
Lymphocyte
|
0.91 (0.87–0.95)
|
< 0.001
|
0.90 (0.86–0.94)
|
< 0.001
|
|
Hemoglobin
|
0.81 (0.70–0.93)
|
0.003
|
0.73 (0.60–0.88)
|
0.001
|
|
Age
|
0.99 (0.98, 1.00)
|
0.187
|
0.99 (0.97, 1.01)
|
0.399
|
|
Gender (Ref.: female)
|
0.86 (0.46, 1.63)
|
0.649
|
0.48 (0.20, 1.14)
|
0.097
|
|
Mortality (as outcome)
|
|
HScore
|
1.02 (1.01–1.03)
|
< 0.001
|
1.02 (1.00–1.04)
|
0.009
|
|
ICU admission
|
25.5 (3.1–209.2)
|
0.003
|
66.06 (3.8–1160.5)
|
0.004
|
|
Systolic Blood pressure
|
0.94 (0.91–0.98)
|
0.006
|
0.93 (0.88–0.98)
|
0.009
|
|
Potassium
|
0.19 (0.05–0.72)
|
0.015
|
0.11 (0.02–0.63)
|
0.013
|
|
Age
|
0.98 (0.95, 1.00)
|
0.098
|
1.06 (0.99, 1.12)
|
0.083
|
|
Gender (Ref.: female)
|
0.47 (0.11, 1.92)
|
0.294
|
0.49 (0.06, 3.87)
|
0.497
|
|
Variables
|
Crude effect measure (95% CI)
|
P value
|
Adjusted effect measure (95% CI)
|
P value
|
|---|
|
Crude HR (95% CI)
|
Adjusted HR (95% CI)
|
|---|
|
Discharge from hospital (as outcome)
|
|
HScore*
| | | | |
|
Moderate
|
0.61 (0.39–0.94)
|
0.024
|
0.60 (0.37–0.97)
|
0.036
|
|
High
|
0.41 (0.24–0.69)
|
0.001
|
0.42 (0.22–0.78)
|
0.007
|
|
Cardiovascular disease
|
0.67 (0.38–1.21)
|
0.185
|
0.40 (0.21- 0.78)
|
0.007
|
|
Respiratory disease
|
4.24 (2.02–8.90)
|
< 0.001
|
5.47 (2.39–12.52)
|
< 0.001
|
|
Chronic kidney disease
|
0.52 (0.13–2.14)
|
0.362
|
11.09 (1.38–89.10)
|
0.024
|
|
Respiratory status
|
1.40 (1.09–1.81)
|
0.009
|
1.34 (1.03–1.74)
|
0.027
|
|
Oxygen therapy
|
0.43 (0.25–0.73)
|
0.002
|
0.22 (0.11- 0.45)
|
< 0.001
|
|
Pneumonia
|
5.26 (2.53–10.94)
|
< 0.001
|
4.56 (1.99–10.46)
|
< 0.001
|
|
Septic shock
|
0.42 (0.20–0.87)
|
0.020
|
0.12 (0.04–0.34)
|
< 0.001
|
|
White blood cell counts
|
0.999 (0.993–1.004)
|
0.719
|
1.006 (1.00–1.01)
|
0.042
|
|
Red blood cell counts
|
1.82 (1.40–2,36)
|
< 0.001
|
1.59 (1.16–2.18)
|
0.004
|
|
Lymphocyte
|
1.03 (1.02–1.04)
|
< 0.001
|
1.03 (1.01–1.04)
|
0.001
|
|
Aspartate aminotransferase
|
0.996 (0.991–1.001)
|
0.178
|
1.006 (1.00–1.01)
|
0.023
|
|
Alanine aminotransferase
|
0.995 (0.989–1.001)
|
0.178
|
0.98 (0.97–0.99)
|
0.011
|
|
Phosphorus
|
0.83 (0.74–0.93)
|
0.002
|
0.82 (0.69–0.98)
|
0.027
|
|
Age
|
0.99 (0.98, 1.00)
|
0.110
|
0.99 (0.98, 1.00)
|
0.419
|
|
Gender (Ref.: female)
|
0.79 (0.54, 1.15)
|
0.217
|
1.13 (0.73, 1.74)
|
0.584
|
- *Moderate and high HScore were compared with low HScore as the reference group
